ஆசியா க்கு ஶிஸேடொ நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆசியா க்கு ஶிஸேடொ நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆசியா க்கு ஶிஸேடொ நிறுவனம் Today - Breaking & Trending Today

RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies


RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
ACCESSWIRE
19 May 2021, 20:05 GMT+10
Clinical Research Organization, Accerise Inc., Has Been Retained To Work With RepliCel and Its Other Service Providers To Prepare Study Documentation, Plans, and Approvals for Clinical Evaluation by Multiple Clinical Sites in Japan
VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained leading clinical research organization, Accerise Inc, with offices in Tokyo and Osaka, to lead the planning and preparations for clinical research studies of RepliCel s skin rejuvenation (RCS-01) and tendon regeneration (RCT-01) cell therapy products in Japan. ....

United States , Hong Kong , British Columbia , Lee Buckler , Replicel Life Sciences Inc , Asia To Shiseido Company , Replicel Life Sciences , Ministry Of Health , Hangzhou Tigermed Consulting Co Ltd , China Health Company , Accerise Inc , Japan Ministry Of Health , Clinical Research Organization , Shiseido Company , Device Agency , Devices Agency , Venture Exchange , Regulation Services Provider , Clinical Evaluation , Multiple Clinical Sites , Professor Morita , Professor Kumai , Regenerative Medicine , Medical Device Agency , Medical Devices Agency , Regenerative Medicines ,

RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map


RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map
ACCESSWIRE
11 May 2021, 20:05 GMT+10
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou. ....

New York , United States , Hong Kong , United Kingdom , British Columbia , Kevin Mcelwee , Youwen Zhou , Lee Buckler , University Of Marburg , Replicel Life Sciences Inc , Hair Research Laboratory , Canadian Dermatology Association , University Of Aberdeen , Institute Of Musculoskeletal Health , Natural Sciences Foundation Of China , University Of Toronto , Vancouver Coastal Health Research Institute At , Skin Health , University Of New York , University Of British Columbia , Skin Sciences , Canadian Institutes For Health Research , Professor Of Biomedical Sciences , Jackson Laboratory , University Of Dundee , Canadian Dermatology Foundation ,